glp-1 discovery receptor biology: structure, signaling, and distribution Glucagon-like peptide-1 - Wikipedia
Description
Someone with severe insulin resistance might benefit more from tirzepatide's stronger effects
International Journal of Molecular Sciences, 25 (23), 12856
The right question isnt which is better? but which makes sense for my case?, and thats answered by a clinician who knows your history
The incidence of nausea was as follows: placebo: 7.7%
